Found: 28
Select item for more details and to access through your institution.
Urine autotaxin levels reflect the disease activity of sarcoidosis.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-08388-6
- By:
- Publication type:
- Article
Treatments and outcomes of advanced/ recurrent non-small cell lung cancer harboring the EGFR T790M mutation: a retrospective observational study of 141 patients in Japan.
- Published in:
- Japanese Journal of Clinical Oncology, 2016, v. 46, n. 12, p. 1135, doi. 10.1093/jjco/hyw124
- By:
- Publication type:
- Article
Efficacy of chemotherapy after first-line gefitinib therapy in EGFR mutation-positive advanced non-small cell lung cancer--data from a randomized Phase III study comparing gefitinib with carboplatin plus paclitaxel (NEJ002).
- Published in:
- Japanese Journal of Clinical Oncology, 2015, v. 45, n. 7, p. 670, doi. 10.1093/jjco/hyv054
- By:
- Publication type:
- Article
Results of the non-small cell lung cancer part of a phase III, open-label, randomized trial evaluating topical corticosteroid therapy for facial acneiform dermatitis induced by EGFR inhibitors: stepwise rank down from potent corticosteroid (FAEISS study, NCCH-1512)
- Published in:
- Supportive Care in Cancer, 2021, v. 29, n. 5, p. 2327, doi. 10.1007/s00520-020-05765-7
- By:
- Publication type:
- Article
A Case of Cutaneous Infection Caused by Mycobacterium Szulgai with Progression to Acute Respiratory Distress Syndrome.
- Published in:
- Clinical Medicine Insights: Case Reports, 2011, n. 4, p. 29, doi. 10.4137/CCRep.S7180
- By:
- Publication type:
- Article
Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas.
- Published in:
- Molecular Cancer, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12943-019-0953-y
- By:
- Publication type:
- Article
Prognostic significance and response to immune checkpoint inhibitors of RIPK3, MLKL and necroptosis in non-small cell lung cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72545-2
- By:
- Publication type:
- Article
Monitoring of Plasma EGFR Mutations during Osimertinib Treatment for NSCLC Patients with Acquired T790M Mutation.
- Published in:
- Cancers, 2023, v. 15, n. 17, p. 4231, doi. 10.3390/cancers15174231
- By:
- Publication type:
- Article
Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study.
- Published in:
- Cancers, 2022, v. 14, n. 16, p. 3993, doi. 10.3390/cancers14163993
- By:
- Publication type:
- Article
Clinical Significance of Tumor Markers for Advanced Thymic Carcinoma: A Retrospective Analysis from the NEJ023 Study.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 331, doi. 10.3390/cancers14020331
- By:
- Publication type:
- Article
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e230698, doi. 10.1001/jamanetworkopen.2023.0698
- By:
- Publication type:
- Article
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational study.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 5, p. 6170, doi. 10.1002/cam4.5349
- By:
- Publication type:
- Article
Targeting stanniocalcin‐1‐expressing tumor cells elicits efficient antitumor effects in a mouse model of human lung cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 3085, doi. 10.1002/cam4.3852
- By:
- Publication type:
- Article
Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 3, p. 632, doi. 10.1002/cam4.220
- By:
- Publication type:
- Article
Plasma or Serum: Which Is Preferable for Mutation Detection in Liquid Biopsy?
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 7, p. 946, doi. 10.1093/clinchem/hvaa103
- By:
- Publication type:
- Article
Phase II trial of daily S‐1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 27, p. 2804, doi. 10.1111/1759-7714.15076
- By:
- Publication type:
- Article
Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02).
- Published in:
- Thoracic Cancer, 2022, v. 13, n. 10, p. 1471, doi. 10.1111/1759-7714.14415
- By:
- Publication type:
- Article
Phase I/II study of biweekly nab‐paclitaxel in patients with platinum‐pretreated non‐small cell lung cancer: NJLCG1402.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 21, p. 2886, doi. 10.1111/1759-7714.14149
- By:
- Publication type:
- Article
A randomized phase II trial of erlotinib vs. S-1 as a third- or fourth-line therapy for patients with wild-type EGFR non-small cell lung cancer (HOT1002).
- Published in:
- 2017
- By:
- Publication type:
- journal article
11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Longitudinal analyses and predictive factors of radiation-induced lung toxicity-related parameters after stereotactic radiotherapy for lung cancer.
- Published in:
- PLoS ONE, 2022, v. 17, n. 12, p. 1, doi. 10.1371/journal.pone.0278707
- By:
- Publication type:
- Article
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive EGFR-mutant Non-small Cell Carcinoma.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 4, p. 515, doi. 10.21873/cdp.10357
- By:
- Publication type:
- Article
Prognostic Factors and Efficacy of First‐Line Chemotherapy in Patients with Advanced Thymic Carcinoma: A Retrospective Analysis of 286 Patients from NEJ023 Study.
- Published in:
- Oncologist, 2018, v. 23, n. 10, p. 1210, doi. 10.1634/theoncologist.2017-0586
- By:
- Publication type:
- Article
Phase II Study of Modified Carboplatin Plus Weekly Nab-Paclitaxel in Elderly Patients with Non-Small Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 1301.
- Published in:
- Oncologist, 2017, v. 22, n. 6, p. 640, doi. 10.1634/theoncologist.2017-0059
- By:
- Publication type:
- Article
A retrospective study of the efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR-TKI monotherapy for PD-L1-positive EGFR-mutant non-small cell lung cancer: North Japan Lung Cancer Study Group 2202.
- Published in:
- Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13920
- By:
- Publication type:
- Article
Significant differences in T cell receptor repertoires in lung adenocarcinomas with and without epidermal growth factor receptor mutations.
- Published in:
- Cancer Science, 2019, v. 110, n. 3, p. 867, doi. 10.1111/cas.13919
- By:
- Publication type:
- Article
Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma.
- Published in:
- Cancer Science, 2016, v. 107, n. 3, p. 320, doi. 10.1111/cas.12876
- By:
- Publication type:
- Article